Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements

Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements

Chronic Lymphocytic Leukemia (CLL) is characterized by the accumulation of monoclonal CD5+ B cells with low surface immunoglobulins (IG). About 40% of CLL clones utilize quasi-identical B cell receptors, defined as stereotyped BCR. CLL-like stereotyped-IG rearrangements are present in normal B cells...

Full description

Bibliographic Details
Main Authors:	Davide Bagnara, Monica Colombo, Daniele Reverberi, Serena Matis, Rosanna Massara, Niccolò Cardente, Gianluca Ubezio, Vanessa Agostini, Luca Agnelli, Antonino Neri, Martina Cardillo, Stefano Vergani, Fabio Ghiotto, Andrea Nicola Mazzarello, Fortunato Morabito, Giovanna Cutrona, Manlio Ferrarini, Franco Fais
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Oncology
Subjects:	chronic lymphocytic leukemia (CLL) immunoglobulin repertoire B-cells CD5 IGHV somatic mutations Ig light chain
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.894419/full

Similar Items

Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia
by: Davide Bagnara, et al.
Published: (2022-11-01)

Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
by: Monica Colombo, et al.
Published: (2020-03-01)

Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
by: Paola Menichini, et al.
Published: (2021-01-01)

Spatial organization and early signaling of the B-cell receptor in CLL
by: Yamit Shorer Arbel, et al.
Published: (2022-08-01)

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
by: Andreas Agathangelidis, et al.
Published: (2023-03-01)

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
by: Fortunato Morabito, et al.
Published: (2021-08-01)

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
by: Francesco Angotzi, et al.
Published: (2024-03-01)

Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors
by: Bella V. Biderman, et al.
Published: (2023-02-01)

The Traf2DNxBCL2-tg Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart
by: Gema Perez-Chacon, et al.
Published: (2021-04-01)

Unexpected CD5<sup>+</sup> B Cell Lymphocytosis during SARS-CoV-2 Infection: Relevance for the Pathophysiology of Chronic Lymphocytic Leukemia
by: Andrea Nicola Mazzarello, et al.
Published: (2023-01-01)

Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights
by: Chiara Salvetti, et al.
Published: (2022-06-01)

Analysis of Mutational Status of <i>IGHV</i>, and Cytokine Polymorphisms as Prognostic Factors in Chronic Lymphocytic Leukemia: The Romanian Experience
by: Beata Balla, et al.
Published: (2024-02-01)

Ibrutinib dose modifications in the management of CLL
by: Camille Hardy-Abeloos, et al.
Published: (2020-06-01)

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
by: Ujjani C, et al.
Published: (2020-08-01)

Challenges in Diagnosis and Clinical Management of COVID-19 in Patient with B-Cell Chronic Lymphocytic Leukemia (CLL): Report of One Case
by: Vincenzo Visco, et al.
Published: (2022-03-01)

Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region
by: Monica Bocchia, et al.
Published: (2020-02-01)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01)

Students’ Perception on The Implementation of Orai Application In CLL Method in Teaching Speaking
by: Halimah, et al.
Published: (2022-05-01)

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial
by: Alexander Egle, et al.
Published: (2019-04-01)

Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
by: Nancy Nisticò, et al.
Published: (2020-09-01)

Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course
by: Davide Bagnara, et al.
Published: (2021-05-01)

The Influence of CLL on EFL Learners’ Speaking Skill
by: Muhammad Ilyas
Published: (2018-08-01)

The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia
by: Alessandro Noto, et al.
Published: (2021-05-01)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
by: Dimitra Mavridou, et al.
Published: (2021-07-01)

Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients
by: Hemanth Tummala, et al.
Published: (2012-12-01)

Review of Venetoclax in CLL, AML and Multiple Myeloma
by: Masa Lasica, et al.
Published: (2021-05-01)

Emerging Therapies in CLL in the Era of Precision Medicine
by: Prajish Iyer, et al.
Published: (2023-03-01)

Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL
by: Kathrin Gärtner, et al.
Published: (2019-12-01)

Critical molecular pathways in CLL therapy
by: Gerardo Ferrer, et al.
Published: (2018-03-01)

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring
by: Stefano Vergani, et al.
Published: (2023-03-01)

The regulatory capacity of B cells directs the aggressiveness of CLL
by: Audrey Mohr, et al.
Published: (2019-03-01)

Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
by: Fabienne Mc Clanahan, et al.
Published: (2011-05-01)

Current strategies for the diagnosis and management of chronic lymphocytic leukemia (CLL), with a focus on poor-risk CLL: A review
by: Fabienne Mc Clanahan, et al.
Published: (2011-06-01)

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia
by: Francesco Forconi, et al.
Published: (2022-01-01)

Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations
by: Ilana Zalcberg, et al.
Published: (2020-07-01)

Effect of Curcumin on Growth Inhibition and Gene Expression Reduction in Chronic Lymphocytic Leukemia Cells(CLL-CII)
by: AM Gholamian, et al.
Published: (2020-04-01)

Diagnosis of B-CLL Leukemia Using Fractal Dimension
by: Tohid Yousefzadeh Hassanluie, et al.
Published: (2017-07-01)

A BALB/c IGHV Reference Set, Defined by Haplotype Analysis of Long-Read VDJ-C Sequences From F1 (BALB/c x C57BL/6) Mice
by: Katherine J. L. Jackson, et al.
Published: (2022-06-01)

Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective
by: Jacqueline Costello, et al.
Published: (2021-09-01)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
by: Lidia Karabon, et al.
Published: (2021-11-01)